Company: SCLXW
Filing Date: 2025-12-29
Form Type: 424B3
Source: 0001193125-25-335429
Chunk: 427

Company: Scilex Holding Co
Filing Date: 2025-12-29
Form: 424B3
Chunk 427
---
 per fiscal quarter at a redemption price equal to
100% of such Amortization Amount (as defined in the Notes).

On January 2, 2025, we entered into the Tranche B Consents pursuant to
which the Tranche B Noteholders agreed to defer our obligation to make the First Amortization Payment until January 31, 2025. In consideration of such deferral, and to limit the Tranche B Noteholders’ right to exercise certain secured
creditor remedies (including recourse against the assets of SCLX JV as a grantor under the Security Agreement (as defined in the Tranche B Consents)), SCLX JV delivered to the Tranche B Noteholders (or their designee) by deposit/withdrawal at
custodian with the Depository Trust Company an aggregate of 142,855 shares of Common Stock (as defined in, and contemplated pursuant to, the Term Sheet) held by SCLX JV, of which 71,428 shares were delivered to Oramed and 71,427 shares in the
aggregate were delivered to the Tranche B Investors.

In addition, pursuant to the Tranche B Consents, effective as of the latest of
(i) the time of execution and delivery of the Tranche B Consents, (ii) the time of the delivery of the Scilex shares and (iii) the time of grant of the Royalty and Exclusive Rights (each as defined in, and contemplated pursuant to,
the Term Sheet), the Tranche B Noteholders agreed to further defer our obligation to make the First Amortization Payment until October 8, 2026, provided that, as contemplated in the Term Sheet, we pay an aggregate of $1.1 million in
respect of a portion of the First Amortization Payment and related make-whole interest (which amount has been paid).

The foregoing
summaries of the Tranche B Consents do not purport to be complete and are qualified in their entirety by reference to the full text of the Tranche B Consents, a copy of each of which is filed as an exhibit to the registration statement of which this
prospectus forms a part.

Amendment to the Oramed Note

On January 21, 2025, we entered into the Oramed Amendment, pursuant to which, among other things, Oramed agreed to extend the Maturity
Date under and as set forth in the Oramed Note from March 21, 2025